Showing results (41-50 of 413) with videos related to
Sort By:
Pageof 42
European Urology|February 10, 2009
Pharmacological approaches to reducing the risk of prostate cancerRoger S Rittmaster, Neil E Fleshner, Ian M ThompsonNature Reviews. Clinical Oncology|November 28, 2013
Future directions in the prevention of prostate cancerIan M Thompson, April B Cabang, Michael J WargovichUrologic Oncology|February 4, 2018
Organizing a clinical trial for the new investigatorJanet Baack Kukreja, Ian M Thompson, Brian F ChapinThe Journal of Urology|August 21, 2002
Impact of previous local treatment for prostate cancer on subsequent metastatic diseaseIan M Thompson, Catherine Tangen, Joseph Basler, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2012
Limited PSA testing in indigent men in South Texas: an appropriate care or missing a prevention opportunity?Yuanyuan Liang, Fei Du, Ian M Thompson, et al.Current Oncology Reports|April 7, 2004
What's new in the field of prostate cancer chemoprevention?Kanwaljit Mahal, Javier Hernandez, Joseph W Basler, et al.Current Urology Reports|May 5, 2005
What's new in the field of prostate cancer chemoprevention?Kanwaljit Mahal, Javier Hernandez, Joseph W Basler, et al.The Journal of Urology|February 1, 2015
Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen TestingStephen Overholser, Matthew Nielsen, Kathleen Torkko, et al.Cold Spring Harbor Perspectives in Medicine|January 10, 2018
Chemoprevention in Prostate Cancer: Current Perspective and Future DirectionsJ Ricardo Rivero, Ian M Thompson, Michael A Liss, et al.The Urologic Clinics of North America|November 5, 2013
Infusion therapy and implantables for the urologistJennifer Rothschild, Ian M Thompson, Raoul S Concepcion, et al.Pageof 42